ARCHIVES

EU Gives Marketing Approval For HBV Sequencing Test

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013

Officials: Poisoning Unrelated to MD Anderson; Critics Allege Dysfunction in Handling of Affair

September 19, 2014

Anti-NCI Forces Fail to Raid $70 Million from Cancer Program

September 26, 1975

Provenge Prolonged Prostate Cancer Survival By Seven Months, Study Finds

September 26, 2003

NIH Alternative Medicine Officer Under Fire For Proposed RFA In Homeopathy, Acupuncture

February 26, 1993

News Analysis: The Political Economy of Importation to Alleviate Cancer Drug Shortages

March 2, 2012